ChemRoutes Corporation is a leading private drug discovery technology provider based in Edmonton, Alberta, Canada. With our expertise at the intersection of organic chemistry, chemical biology, drug discovery, and nanotechnology, we have been at the forefront of the industry since our establishment in 1999. Our team comprises experienced scientists and a distinguished scientific advisory board, allowing us to have a comprehensive understanding of the drug discovery and development process.

We specialize in early-stage drug discovery to pre-clinical research, focusing on a wide range of diseases including infectious, neurodegenerative, and metabolic diseases, as well as pain, inflammation, and oncology. At ChemRoutes, we are proud of our track record of delivering consistent results, which has led to partnerships with over 80 global pharmaceutical, agrochemical, and biotech companies. Through our proprietary and innovative small molecule-based scaffolds, building blocks, templates, chemical arrays, and new chemical target research, we provide cutting-edge platforms for the discovery of new molecular targets and biochemical pathways.

Our core values include pursuing integrity and reliability, adapting to future trends, collaborating effectively, and delivering products with optimal costs, speed, and quality. We strive to create value for our stakeholders and take accountability for our actions and their results. Choose ChemRoutes for unparalleled expertise and innovative solutions in drug discovery technology